Drug Profile
AFX 221
Alternative Names: AFX-221; Molindone - Afecta Pharmaceuticals; NGI-221Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Afecta Pharmaceuticals
- Class Antipsychotics; Behavioural disorder therapies; Indoles; Small molecules
- Mechanism of Action Dopamine D2 receptor antagonists; Neurotransmitter modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Phase Unknown Attention-deficit hyperactivity disorder; Gilles de la Tourette's syndrome
Most Recent Events
- 20 Jun 2008 Investigation in Attention-deficit hyperactivity disorder in USA (PO)
- 20 Jun 2008 Investigation in Gilles de la Tourette's syndrome in USA (PO)